Patents by Inventor Marcia Angela Van Valen
Marcia Angela Van Valen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8603079Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: GrantFiled: February 1, 2013Date of Patent: December 10, 2013Assignee: Biolase, Inc.Inventor: Marcia Angela Van Valen
-
Patent number: 8602033Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: January 19, 2011Date of Patent: December 10, 2013Assignee: Biolase, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 8568392Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: October 29, 2007Date of Patent: October 29, 2013Assignee: Biolase, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 8448645Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: June 27, 2011Date of Patent: May 28, 2013Assignee: Biolase, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 8366702Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: GrantFiled: December 21, 2010Date of Patent: February 5, 2013Assignee: Biolase, Inc.Inventor: Marcia Angela Van Valen
-
Patent number: 8276593Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: March 22, 2011Date of Patent: October 2, 2012Assignee: BIOLASE, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 8256431Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: GrantFiled: October 30, 2007Date of Patent: September 4, 2012Assignee: BIOLASE, Inc.Inventor: Marcia Angela Van Valen
-
Patent number: 8056564Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: November 3, 2008Date of Patent: November 15, 2011Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Publication number: 20110257639Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: ApplicationFiled: June 27, 2011Publication date: October 20, 2011Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 7997279Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: November 3, 2008Date of Patent: August 16, 2011Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Publication number: 20110192405Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: ApplicationFiled: January 19, 2011Publication date: August 11, 2011Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Publication number: 20110172650Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: ApplicationFiled: March 22, 2011Publication date: July 14, 2011Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 7967017Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: October 17, 2007Date of Patent: June 28, 2011Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Publication number: 20110092964Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: ApplicationFiled: December 21, 2010Publication date: April 21, 2011Inventor: Marcia Angela Van Valen
-
Patent number: 7909040Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: October 4, 2007Date of Patent: March 22, 2011Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 7891363Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: October 29, 2007Date of Patent: February 22, 2011Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Patent number: 7878204Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: GrantFiled: April 24, 2006Date of Patent: February 1, 2011Assignee: Biolase Technology, Inc.Inventor: Marcia Angela Van Valen
-
Patent number: 7867223Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.Type: GrantFiled: October 30, 2007Date of Patent: January 11, 2011Assignee: Biolase Technology, Inc.Inventor: Marcia Angela Van Valen
-
Patent number: 7665467Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: GrantFiled: April 26, 2006Date of Patent: February 23, 2010Assignee: Biolase Technology, Inc.Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
-
Publication number: 20090118719Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.Type: ApplicationFiled: November 3, 2008Publication date: May 7, 2009Inventors: Jeffrey W. Jones, Marcia Angela Van Valen